ADME-Toxicology Testing Global Market Report 2022: Increased Need to Check Late-Stage Drug Failures Drives Growth – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “ADME-Toxicology Testing – Global Market Trajectory & Analytics” report has been added to ResearchAndMarkets.com’s offering. Global ADME-Toxicology Testing Market to Reach $12.3 Billion by 2027 In the changed post COVID-19 business landscape, the global market for ADME-Toxicology Testing estimated at US$6 Billion in the year 2020, is projected to reach a revised size … [Read more…]

The Worldwide Antibacterial Coatings Industry is Expected to Reach $1 Billion by 2030 – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Antibacterial Coatings Market for Medical Implants By Material, By Type: Global Opportunity Analysis and Industry Forecast, 2020-2030” report has been added to ResearchAndMarkets.com’s offering. The anti-bacterial coatings market for medical implants was valued at $234.42 million in 2020, and is estimated to reach $1,072.27 million by 2030, growing at a CAGR of 16.4% … [Read more…]

Abalos Therapeutics Appoints Thomas Bogenrieder as Chief Medical Officer

DÜSSELDORF, Germany–(BUSINESS WIRE)–Abalos Therapeutics announced today the appointment of Thomas Bogenrieder, MD, PhD, as Chief Medical Officer. Dr. Bogenrieder will contribute more than 17 years of international clinical development experience including successfully guiding cancer immunotherapies through the clinical evaluation process. His expertise in the clinical development of cancer virotherapies will further strengthen the company’s leadership … [Read more…]

Lysando AG and Amicogen Inc. Sign General Development Agreement

TRIESENBERG, Liechtenstein–(BUSINESS WIRE)–#UTI–Lysando AG – market leader in the field of antimicrobial proteins – has signed a general development agreement with Amicogen Inc., a publicly traded biotechnology company and CDMO headquartered in South Korea. In August last year, Lysando and Amicogen entered into a strategic partnership backed up by a mutual participation model. This collaboration … [Read more…]

Vagaro Offering Key Tools to Small Business Owners as U.K. Inflation Remains at Record Highs

LONDON–(BUSINESS WIRE)–As inflation across the U.K. remains at record highs, with reports earlier this year revealing prices rising at the fastest pace in 40 years, Vagaro seeks to lessen the burden of maintaining business operations and financial woes on small business owners during this time. Vagaro, the leading comprehensive business management platform for the beauty, … [Read more…]

CMP Scientific Signs a Co-Marketing Agreement with Agilent to Advance Capillary Electrophoresis–Mass Spectrometry Solutions

BROOKLYN, N.Y.–(BUSINESS WIRE)–#BioSpace–CMP Scientific Corp., a leader in Capillary Electrophoresis-Mass Spectrometry (CE-MS) technologies, today announced that it has signed a global co-marketing agreement with Agilent Technologies to provide an integrated CE-MS solution to life science and pharmaceutical industry. CMP Scientific develops, manufactures, and sells products and analytical instruments in life sciences, diagnostics, and applied markets. … [Read more…]

BD, BIOCORP Sign Agreement to Bring Connectivity, Traceability to Self-Administered Injectable Drugs

Companies to Explore Opportunities to Integrate Biocorp’s Injay® Technology with BD UltraSafePlus™ Passive Needle Guard to Help Biopharmaceutical Manufacturers Capture and Transmit Self-Administered Injection Data. FRANKLIN LAKES, N.J.–(BUSINESS WIRE)–#digitalhealth–Regulatory News: BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biocorp (Paris:ALCOR), a medical device and delivery systems manufacturer based in … [Read more…]

57% of Doctors See Patients Turning to Private Care

A survey of 467 UK physicians revealed that more than 9 in 10 (91%) doctors have seen an increase in patients struggling to access medical healthcare services in the last 5 years 9 in 10 (90%) doctors are seeing an increase in waiting lists, with access to healthcare being seen as the number one concern … [Read more…]

Eucure Biopharma, a Subsidiary of Biocytogen Pharmaceuticals, Licenses OX40 Antibody (YH002) and Multiple Active Ingredients to Syncromune for the Development and Commercialization of Intratumoral Immunotherapy

BEIJING, China & FORT LAUDERDALE, Fla.–(BUSINESS WIRE)–#Biocytogen–Eucure (Beijing) Biopharma Co., Ltd. (“Eucure”), a wholly owned subsidiary of Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (“Biocytogen”), announced today that the company has entered into a worldwide licensing agreement with Syncromune, Inc. (“Syncromune”), a US-based clinical stage biopharmaceutical company, for the development and commercialization of intratumoral immunotherapies along with … [Read more…]

Racism Has No Place in Global Public Health, says AHF

KAMPALA, Uganda–(BUSINESS WIRE)–#Africa–AIDS Healthcare Foundation (AHF) voiced support today for African leaders, experts and advocates who have endured humiliation and discrimination while attempting to travel to wealthy countries in their official capacities. Dr. Ahmed Ogwell Ouma, a Kenyan national and acting director of the Africa Centres for Disease Control and Prevention, decided to return home … [Read more…]